trending Market Intelligence /marketintelligence/en/news-insights/trending/IdWDCYtwerAXFMxBxBV6GQ2 content esgSubNav
In This List

PTC Therapeutics chief commercial officer stepping down

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Infographic

Infographic: The Big Picture 2023 Sustainability Outlook

Blog

The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism


PTC Therapeutics chief commercial officer stepping down

Mark Rothera agreed to step down as chief commercial officer of PTC Therapeutics Inc., effective Aug. 9.

Rothera entered into a consulting agreement, effective Aug. 10, 2017, with a term continuing through Sept. 30, 2018.